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ABSTRACT 
Submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy 
Joseph V. Califano, D. D. S. 
Virginia Commonwealth University 
Advisor: Dr. John G. Tew 
This study was initiated to look for characteristics of the 
irnmunodominant antigen(s) of Actinobacillus actinomycetemcomitans (Aa) 
that might help explain the high antibody titers reactive with this organism in 
periodontitis patients. Radioimmunoassays (RIA) and limiting dilution 
analysis on western blots were used to identify and characterize the 
irnmunodominant antigens of Aa in high responder patients (Le. patients with 
high antibody titers). Additional experiments focused on specific responding 
subjects with a range of antibody titers to serotype b (AaY4). This group 
included both white and black subjects. Similar studies then examined the 
irnmunodominant antigens of Aa serotypes a and c. The Aa serotype 
specificity of the high responders was determined and further work was 
confined to individuals responding specifically to serotypes a or c. The 
results indicated that the irnmunodominant antigen of Aa Y 4 in all high 
responders was heat and papain stable. Limiting dilution analysis on western 
x 
blots showed that a large diffuse band resembling carbohydrate was the 
immunodominant antigen. Partially purified AaY4 carbohydrate also 
contained the large diffuse band. Double immunodiffusion (Ouchterlony) 
tests indicated that the dominant antigen recognized in the carbohydrate 
extract by the patients' sera was the same antigen recognized by serotype b 
specific rabbit antiserum which has been previously shown to react with the 
serotype specific carbohydrate of AaY4. When the subjects with specific 
antibody responses covering a range of positive antibody titers were 
examined, 95% of the subjects were responding to the smeared serotype 
specific carbohydrate antigen on western blots. For serotype-a, no 
immunodominant antigen was common to the majority of high responding 
subjects. For serotype-c two antigens were immunodominant in the majority 
of the high responding patients: 92% had an antigen with a diffuse smeared 
appearance on western blots typical of a carbohydrate antigen and 67% had 
an approximately 1 5Kd antigen. The smeared antigen gave a reaction of 
identity with patient serum and serotype c specific rabbit antiserum in 
double immunodiffusion assays. These findings indicated that the 
immunodominant antigen for serotypes-b and-c in high responding subjects 
was the serotype specific carbohydrate. The same antigen was 
immunodominant for subjects with a range of antibody titers to AaY4. The 
dominant antigen was highly variable for serotype-a. These antigens were 
highly immunogenic. This immunogenicity may explain the enormous 
antibody titers observed for Aa in response to what appears to be a small 
quantity of antigen. 
INTRODUCTION 
Periodontal disease is characterized by loss of the supporting tissues of teeth. 
It has been shown that the tissue destruction associated with the disease only 
occurs in the presence of bacterial plaque. As the disease progresses the 
normal relationship of the gingiva, gingival connective tissue, and bone, with 
the tooth is lost. Normally, teeth are attached to supporting bone by 
periodontal ligament fibers which extend from the cementum of the tooth 
into the alveolar bone. The gingiva in a similar manner is attached to the 
tooth by connective tissue fibers. In health they attach to a small amount of 
root surface that is not within the alveolar bone. Therefore, the gingival 
attachment extends coronally to the enamel (i.e. the cementoenamel 
junction). Periodontal disease begins as the gingival fibers detach from the 
root surface. This is followed by loss of alveolar bone and periodontal 
ligament fibers. This attachment loss can become extreme resulting in tooth 
loss. There are three major types of periodontal disease: adult periodontitis, 
severe periodontitis (generalized juvenile periodontitis or rapidly 
progressive periodontitis), and juvenile periodontitis (localized). Adult 
periodontitis is characterized by comparatively slow loss of attachment with 
active and stable periods throughout a patient's life. Severe periodontitis is a 
type of early onset periodontitis where all or many of the patient's teeth are 
affected by rapid attachment loss. Individuals with this disease are clinically 
identified by their young age and rapid rate of periodontal destruction. 
Severe periodontitis has similar characteristics to juvenile periodontitis and, 
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therefore, is sometimes referred to as generalized juvenile periodontitis. 
Localized juvenile periodontitis is another form of early onset periodontitis 
that usually begins during puberty. It has a localized pattern of disease 
affecting first molars and incisors preferentially. Additional teeth may 
become affected as the individual becomes older. Older individuals that have 
a generalized pattern of attachment loss where an earlier localized pattern of 
disease can be documented are often classified as juvenile periodontitis 
patients. The bony lesions in these subjects are typically deep vertical defects 
with the adjacent tooth unaffected. Early onset forms of periodontal disease 
have a familial tendency which suggests a genetic basis to these diseases. In 
addition, juvenile periodontitis patients often have defects in neutrophil 
chemotaxis. It is also interesting to note that a similar immune defect can be 
found in juvenile diabetic patients with early onset periodontal disease (15). 
There has been considerable debate concerning the specific and non­
specific plaque hypothesis. The specific plaque hypothesis suggests one 
organism is the primary etiologic agent for periodontal disease. This 
hypothesis would then support the idea that Koch's postulates could be 
satisfied for periodontal disease. The non-specific plaque hypothesis suggests 
that periodontal disease is a function of increased bacterial load with the same 
species in the same relative amounts as found in health. While this issue is 
still a matter of debate, it appears that the non-specific plaque hypothesis does 
not describe the flora found in diseased individuals. Periodontal patients not 
only have an increase in total numbers of bacteria, but the composition of the 
flora is altered (19). There is a shift from a flora where gram positive cocci 
predominate to one where gram negative anaerobic bacilli predominate. It 
may be that this general shift to gram negative organisms results in disease. 
In this case a mixed infection of predominantly gram negative anaerobic rods 
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would result in disease in susceptible individuals. It still remains a possibility 
that one or only a few specific organisms are responsible for disease. Three 
to four hundred organisms have been identified in sites affected with 
periodontal disease. Many of these organisms are difficult to culture. 
Utilizing the most effective techniques available, it is still not possible to 
culture all of the organisms present in the periodontal lesion. An important 
pathogen may be missed (possible example: the "large Treponeme") (1 9). 
Some of the four hundred bacterial species have strong association with 
periodontal disease even though they have yet to satisfy Koch's postulates. 
Actinobacillus actinomycetemcomitans (Aa), a gram negative organism 
frequently isolated from lesions of juvenile periodontitis ( 1 , 13 , 19,30), is 
thought to be a major etiologic agent of this form of periodontal disease (21).  
There has been some disagreement on the degree of association with disease 
and the proportion of the flora in diseased sites. Some investigators have 
indicated that this organism is found in large numbers in almost all juvenile 
periodontitis lesions (32,1). Others have found the organism associated with 
diseased sites less frequently and in a smaller proportion of the flora (19).  
Actinobacillus actinomycetemcomitans (AaY4) has been shown to elicit 
remarkably high antibody titers in juvenile periodontitis (4, 16,18,20,25,26). 
This antibody response has been shown to be protective in patients with early 
onset periodontits (6). Individuals that find the organism frequently in high 
numbers cite this data as evidence that the organism is indeed highly 
prevalent among juvenile periodontitis patients. They suggest that the high 
antibody titers are the result of large numbers of Aa organisms being present 
in the periodontal pocket (30,32). However, other periodontitis associated 
organisms such as Fusobacterium nucleatum elicit comparatively lower titers 
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(24,25) even though they represent a larger proportion of the flora for most 
patients (19). 
Rational For This Study 
This study was initiated to examine the immunodominant antigens of 
Actinobacillus actinomycetemcomitans. It was reasoned that the 
immunodominant antigens of Aa might have unique characteristics that 
might make them potent immunogens. This would explain the enormous 
antibody titers reactive with this organism that have been observed. 
Identifying the immunodominant antigens might also provide information 
regarding a patient's prognosis as antibody to this organism has been shown 
to be protective (6). The immunodominant antigens might also make good 
candidates for vaccines that could elicit a protective response. 
The results of this study showed that the immunodominant antigen for Aa 
serotype-a was highly variable from patient to patient. In contrast, most 
patients with high antibody titers to serotype-c responded to a 15Kd protein 
antigen and/or a smeared antigen. The immunodominant antigen for Aa 
serotype b (Aa Y 4) in both high responders and specific responders over a 
range of antibody titers was also a smeared antigen. This smeared antigen 
recognized by patient serum was also recognized by serotype specific rabbit 
antiserum. These data support the conclusion that the smeared 
immunodominant antigen was the serotype specific carbohydrate which 
appears to be part of the Aa capsule (30,31 ,32). The carbohydrate antigens 
therefore appear to be highly immunogenic and may be important antigens 
for Aa serotypes-b and-c. This potent immunogenicity may explain the 
enormous antibody titers that are found even when Aa Y 4 is found in low 
numbers. 
MATERIALS AND METHODS 
Human SUbjects 
1 .  Immunodominant Antigen for Actinobacillus actinomycetemcomitans 
Strain Y 4 in High Responder Patients 
Subjects for these studies included 481 clinically characterized patients {227 
black, 249 white, 3 Asian, 2 Indian (Asian) } at the Medical College of 
Virginia/Virginia Commonwealth University Clinical Research Center for 
Periodontal Diseases. These patients were diagnosed as follows: 76 juvenile 
periodontitis, 72 severe periodontitis, 103 adult periodontitis, and 230 non­
periodontitis. 
2. Immunodominant Antigens of Actinobacillus actinomycetemcomitans 
Serotype b in Early Onset Periodontitis Patients 
Subj ects for these studies were selected from a group of 99 early 
onset  peri odonti ti s pati ents at the Medi c al C ol lege  of 
Virginia/Virgini a  C ommonwealth Universi ty C linical Research C enter 
for Peri odontal Di seases . The group of 99 subjects i ncluded 47 
locali zed juveni le peri odontiti s (IP) (39 Black, 9 whi te) and 52 
generalized severe early onset periodonti ti s  ( SP) (28 black ,  24 whi te) 
pati ents. E leven AaY4 seroposi tive whi te, early onset periodontiti s  
subjects wi th a range of antibody ti ters were selected for study ( see 
Table 1 ) .  Black subjects were then selected who had antibody ti ters 
comparable to those found among the white subjects. Our study 
group i ncluded 18 black subjects and 1 1  white subjects. Thi s 
5 
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included 2 1  individuals with severe periodontitis (SP) and 8 
individuals with juvenile periodontitis (JP). 
3 .  Immunodominant Antigens of Actinobacillus actinomycetemcomitans 
Serotypes a and c in High responder Patients 
Subjects for these studies included 1 50 clinically characterized 
patients at the Medical College of Virginia/Virginia Commonwealth 
University Clinical Research Center for Periodontal Diseases. 
Specific criteria for each of these categories are the following: 
(1) Juvenile periodontitis (JP): Subjects were 30 years of age or less with a 
localized pattern of severe periodontal destruction limited to first molar or 
incisor teeth and up to two additional teeth. 
(2) Severe periodontitis (SP): Subjects were 3 5  years of age or less with a 
generalized pattern of severe destruction with attachment loss of at least 5 
mm on 8 or more teeth, at least 3 of which were not first molars or incisors. 
(3) Adult periodontitis (AP): Subjects were greater than 35 years of age 
with chronic periodontitis generalized to all four quadrants of the mouth. 
(4) Non-periodontitis (NP): Subjects of any age who had no evidence of 
attachment loss, except recession on the buccal surface of anterior teeth, and 
no more than one site or pockets no greater than 3mm. 
Bacteria and Antigen preparation 
Actinobacillus actinomycetemcomitans serotypes a, b, and c (VPI strain 
numbers: 14554,13 127, 14573 respectively) and Bacteroides gingivalis strain 
D43B-4 were grown in mass culture by W.E.C. Moore and L.V.H. Moore of 
Virginia Polytechnic Institute and State University. The bacterial strains 
were centrifuged, frozen, shipped to the Medical College of Virginia, 
Richmond, sonicated, and used to coat polystyrene RIA strips or run on 
western blots. Protein concentrations in the sonicates were determined by 
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the method of Lowry et al (17). Tetanus toxoid, used as a control, was the 
generous gift of Lederle, Inc. 
Radioimmunoassay 
Details of the solid-phase radioimmunoassay technique used for detection 
and quantitation of specific antibody have been described (24). Briefly, 200 
microliters of sonicated bacteria or TT (25-100 micrograms per ml in 
carbonate buffer, pH 9.6), was placed in each well of plastic assay strips 
(Imrnulon 2; Dynatech Laboratories, Inc., Alexandria, Va.). The strips were 
then incubated at 40C for 1 6  hours and then washed in tap water 20 times. 
Sera were serially diluted (in the range of 1 :50 to 1 :  1 02,400) in diluent 
(equal volumes of distilled water containing 10% nonfat dry milk and PBS, 
pH 7.2). Each dilution of serum was added to two antigen coated wells and 
two uncoated wells. The final quantity of serum in the well varied from 
1 /250 m1 in the first well to 1/5 12,000 ml in the final well. The uncoated 
wells served as a background control. After incubation and washing as 
described above, 200 microliters of iodinated (specific activity, 25 uCi/ ug) 
goat anti-human IgG (Fc specific) in diluent was added per well. After 
incubation and washing, radioactivity was measured to an accuracy of 
1 O%(LKB instruments Inc., Rockville, Md; 1282 Compugamma Counter). 
The difference in counts (delta cpm between coated and uncoated wells) was 
the basic data unit. A plot of delta cpm versus serum dilution was prepared. 
A cut-off was selected (generally 3000-10,000 delta cpm) that intersected the 
curve at the end of the linear portion of the curve or point of inflection. This 
was designated as the endpoint. The titer of the serum antibody was the 
inverse of the dilution at the endpoint. 
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Western Blot Analysis 
Antigen preparations were diluted to the appropriate concentration for the 
particular antigen (Aa 5ug/50ul, Bg 20ug/50ul, Tetanus toxoid 20ug/50ul) in 
sample buffer (0.0626M Tris 10% glycerol 2.3% SDS pH 6.8) and boiled for 
90 seconds. The running buffer was 0.025M Tris containing 0.192M 
Glycine and 0.1 % SDS. 5-20% linear gradient polyacrylamide gels were run 
at 30 milliamperes per gel until the smallest prestained molecular weight 
marker (Bethesda Research Laboratories Life Technologies, Inc. 
Gaithersburg, MD.) reached the bottom of the gel (approximately 5 hours). 
A BIO-RAD SE600 vertical gel apparatus and a BIO-RAD power supply 
model 500/200 were used. Following electrophoresis the antigens were then 
blotted to nitrocellulose in a BIO-RAD transblot cell for 5 hours at 200 
milliamperes. The blots were incubated in equal volumes of distilled water 
containing 10% nonfat dry milk and PBS, pH 7.2 for 1 hour to block non­
specific binding (11). The blots were then cut into individual lanes to allow 
treatment of replicate lanes with different dilutions of serum (diluted in equal 
volumes of distilled water containing 10% nonfat dry milk and PBS, pH 7.2). 
Each lane was incubated in 4 ml of diluent containing 0.5 ml of serum at the 
lowest dilution and 1/1024,000 ml serum at the highest dilution. The 
separate nitrocellulose lanes were then incubated with patient serum for 16 
hours (1-3 hours in some experiments) followed by 4 ten minute washes with 
TTBS (Tween-20 Tris Buffered Saline). The 16 hour incubation was 
necessary to improve sensitivity. The lanes were then exposed to a 1:1000 
dilution of alkaline phosphatase labeled goat anti-human IgG (H & L)(KPI 
laboratories Inc., Gaithersburg, MD.) for 4 hours. This was followed by 4 
more washes with TTBS. The blots were developed with the BCIP/NBT (5-
bromo-4-chloro-3-indoyl phosphate/nitro blue tetrazolium) phosphatase 
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substrate system. Some of the SDS-page gels were also stained with 
Coomassie brilliant blue (Bio-Rad, 220 Maple Ave. Rockville Centre, N. Y. 
11571) or Silver stain (Bio-Rad silver stain kit, Bio-Rad, 220 Maple Ave. 
Rockville Centre, N. Y. 11571) (the method used was that described in the 
Bio-Rad Trans-Blot and Inunun-Blot instruction manuals included with the 
Trans-Blot unit). 
C ompetition Assay 
To determine the specificity of the antibody response for each patient the 
competition assay was developed. Four replicate nitrocellulose lanes (for 
each serotype) were stained (as described above in the western blot 
technique, except incubation with primary and secondary antibody was for 
one hour each). The patient serum used was either untreated or incubated 
overnight with serotype-a, -b, or-c antigen (see Fig. 1 for illustration). It is 
important to note that a large quantity of antigen was required to completely 
eliminate staining (i.e. completely eliminate reactivity from the serum) in 
some patients. To completely absorb antibody molecules reactive with the 
antigen, serum was incubated (diluted 1/250) overnight with 3000ug of 
antigen followed by an overnight incubation with antigen coated petri dishes. 
These petri dishes were coated with antigen in the same manner as micro titer 
plates in the RIA (24). The patients' sera were then centrifuged in a 
rnicrofuge at 6000 X g for 10 minutes to remove any insoluble material. 
Double Immunodiffusion 
Double immunodiffusion precipitin reactions were performed in agar gels 
(Ouchterlony test), using the slide micromethod (20). The well cutters were 
selected to produce wells of 10ul capacity in the center and six 
circumferencial wells. The center well received 40ul of Aa Y 4 carbohydrate 
extract added in l Oul increments. The peripheral well received SuI of a 1/2 
1 0  
dilution of human serum or rabbit serotype specific antiserum. After the 
precipitin pattern developed, the gels were washed to remove excess protein, 
dried and stained at room temperature in a 0.5% solution of Coomassie blue 
R-250 in 10% acetic acid, 25% isopropanol in water. The excess stain was 
removed by washing the slides in a 10% acetic acid solution. The rabbit 
serotype specific antisera were the kind gift of Dr. Joseph Zambon of 
Buffalo, NY. 
Immunoelectrophoresis 
Immunoelectrophoresis was conducted in a 1.0% agarose gel in 0.02M 
TRIS-barbiturate, pH 8.6 using a Pharmacia Flat Bed Apparatus with cooling 
plate following the method described in the unit's instruction manual. 
(Pharmacia Inc., 800 Centennial Ave. Piscataway, N.J. 08854). AaY4 
sonicate ( l0u1 sonicate containing 43ug/ml protein) or AaY4 carbohydrate 
extract (lOul) were added to the wells and electrophoresed for 60 minutes at 
l OV/cm while cooled to 1O-140C. The troughs were then filled with 100ul of 
a 1:8 dilution (as per instruction manual) of human serum and incubated at 
room temperature for 18 hours. The gel was then pressed, washed (in PBS 
pH 7.4 for 18 hours followed by a 60 min. wash in deionized water), and 
dried. The gel was then stained with Coomassie blue. 
Papain Digestion 
Proteolytic digestion was accomplished by adding 200ul of papain (Sigma) 
solution per well (containing O.l mg /ml in O.IM Phosphate,with O.OOIM Cys 
0.002 ETDA buffer pH 6.2) to antigen coated plates and incubated for 4 
hours at 370C (25). The antigen was digested after coating of microtiter 
plates as it was reasoned this would prevent competition for binding sites on 
the plates by papain (also a protein). The plates were then washed 20 times in 
tap water. For western blots, papain solution was prepared as above with 7.5 
1 1 
mg/mI papain and the appropriate antigen was added to a concentration of 1 
mg/mI. This mixture was then incubated for 4 hours at 370C. Following the 
incubation, the mixture was concentrated to 0.5 ml with a Centriprep 
concentrator (Ami con Corp. Scientific Systems Division, Danvers. MA) and 
then diluted to the same concentration used for undigested antigen. 
Protease K Digestion 
Proteolytic digestion was accomplished by placing a nitrocellulose lane 
that had electrophoretically separated Aa serotype-c antigens electroblotted 
to it in sample buffer (0.026 M Tris, 10% glycerol, 2.35 sodium dodecyl 
sulfate [SDS] [pH 6.8]) containing 50 ug/mI protease K for 4 hours at 370C. 
Proteolytic digestion of serotype-c sonicate (7ug protein/ml in PBS) was 
accomplished by adding protease K to a concentration of 200ug/m1 and 
incubating overnight at 370C. 
Heat Treatment 
Antigen preparations (Aa, Bg, or TT) were placed in a boiling water bath 
for 45 minutes. Various temperatures and times studied in preliminary 
experiments indicated that boiling for 45 minutes was necessary to virtually 
eliminate reactivity with tetanus toxoid and Bg controls. 
Carbohydrate Purification 
Carbohydrate was partially purified from Aa by extraction with phenol 
and water followed by precipitation of the carbohydrate from the aqueous 
phase with cold ethanol (9). One milliliter of AaY4 whole cells (7S.5mg/ml) 
was pelleted in an Eppendorf Microfuge. The pellet was then resolubilized in 
23ml of 0.05M Tris,O.OOl METDA, 50ug/mI lysozyme (pH 7.5), and 
incubated for 15 minutes at 370C. SDS was then added to a concentration of 
1.5% to gently lyse the cells. Forty six milliliters of phenol were added and 
the mixture shaken for 15 minutes. The mixture was then centrifuged at 
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5900 X .G for 10 minutes at 40C. The aqueous layer was removed and two 
volumes of cold 95% ethanol was slowly added. The mixture was then 
centrifuged at 5900 X g for 10 minutes at 40C. The precipitate was then 
dissolved in 23rnl of 20mM phosphate buffer. Ribonuclease (40uglrnl) and 
deoxyribonuclease (40ug/ml) were added and incubated for 1 hour at 370C. 
The extracted carbohydrate was concentrated to 0.5 rnl with a Centriprep 
concentrator (Amicon corp.-Scientific Systems Division, Danvers, MA) and 
then diluted in sample buffer one sixth the original volume. In some 
experiments, low molecular weight material was removed by concentrating 
the extracted carbohydrate with a Centriprep concentrator having a 30kd 
molecular weight cut off. This was accomplished with 3 cycles of 
concentration and resuspension in 10 ml deionized water. In some 
experiments, lipopolysaccharide was removed from the carbohydrate extract 
with a lipid A binding affinity column (Detoxi-Gel; Pierce, Inc. box 117 
Rockford, lli. 61105). The column was equilibrated with 3 bed volumes of 
PBS pH 7.5. Twenty microliters of carbohydrate extract was then added to 
the column which represented microgram amounts of LPS. According to the 
manufacturer, each column has a binding capacity of 2 milligrams of LPS. 
Six bed volumes of PBS were then added. Six bed volumes of effluent were 
collected and concentrated with a centriprep concetrator. 
LPS Purification 
Actinobacillus actinoinycetemcomitans lipopolysaccharide (a kind gift of 
Dr. Frank Nichols, Univ. of Connecticut School of Dental Medicine) was 
purified by the method of Westphal (28). Analysis of the phenoVwater LPS 
extract on Coomassie stained SDS-page gels revealed several protein bands. 
This Aa Y 4 LPS preparation was therefore further treated with papain as 
described above to digest contaminating protein. 
RESULTS 
1. hnmunodominant Antigen for Actinobacillus actinomycetemcomitans 
Strain Y 4 in High Responder Patients 
In order to identify subjects with high anti-AaY4 antibody titers, sera 
from 481 patients were assayed. Thirty-two subjects with the highest anti­
AaY4 antibody titers (i.e. above 128,000 RIA units/ml) were selected for 
further analysis. This was less than 10% of the total group with 26 being 
black, 4 white, and 2 Asian. All but 2 of these subjects had early onset forms 
of periodontitis i.e., 17JP, 13SP, lAP, and 1NP. 
To determine the nature of the immunodominant antigens of Aa Y 4, 
antigen preparations were first subjected to heat treatment or papain 
digestion. Antibody titers to these altered antigens were then determined by 
RIA. Representative plots of delta CPM versus reciprocal dilution for Aa Y 4 
as well as TT and Bg which served as controls are shown in Figure 1. For 
tetanus toxoid (Fig. 1 panel A) the titer for untreated antigen was 16,000 RIA 
units/ml. Boiling the antigen decreased the titer to 2000 RIA units/ml and 
papain digestion reduced the titer to 750 RIA units/ml. Similarly for Bg 
(Fig. 1 panel B), a titer of 16,000 RIA units/ml for untreated antigen was 
decreased to 4,000 RIA units/ml by papain and less than 500 RIA units/ml for 
boiling. In contrast, a titer of 256,000 RIA units/ml for Aa (Fig. 1 panel C) 
was unaffected by papain and only modestly decreased by boiling for 45 
13 
14 
FIG. 1. Typical RIA curves showing the effect of boiling C+), and papain 
digestion C-) of antigen on antibody titers as compared to untreated antigen 
CD). Panels a, b, and c, respectively illustrate the antigens IT, Bg, and AaY4. 
The dotted line locates the cut-off for each curve. The cut-off marks the point 
in the linear portion of the curve slightly before the inflection point in the 
lower portion of the curve. The antibody titer is defined as the inverse of the 
serum dilution at the end point. 
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minutes. The mean antibody titers for all 32 patients' sera is summarized in 
Figure 2. These results indicate that the antibody titer for IT (this control 
was applied to 4 of the 32 subjects) was virtually eliminated by both papain 
treatment and boiling. In contrast, antibody titers against Aa Y 4 were 
unaffected by papain digestion and only modestly decreased by boiling. 
To more directly examine individual antigens responsible for the antibody 
responses, westem blots were prepared. As a control for the effectiveness of 
enzyme digestion, Bg antigen was examined by westem blot analysis with and 
without papain treatment. At low dilution of patient serum, there were over 
30 discrete bands for Bg (Fig. 3 "Bg"). With papain digestion, the protein 
bands were eliminated leaving the characteristic "step ladder" effect 
commonly associated with lipopolysaccharide (LPS) (Fig. 3 "Bg pap"). 
When the AaY4 antigen preparation was analyzed using 0.5 ml of patient 
serum in the incubation mixture (Fig. 3 "Aa"), about 50 discrete bands were 
present. In addition to these bands there was also a diffuse band or "smear" 
observed in the upper portion of the lane. Although the location of the 
protein bands were highly reproducible from gel to gel, this diffuse smear 
was not. Generally the smear occupied the upper half of the gel beginning at 
the origin; but sometimes this smear did not begin until the level of the 200kd 
molecular weight marker. If the Aa Y 4 antigen was boiled for 45 minutes 
before western blot analysis, many of the discrete protein bands disappeared 
but the smear persisted (Fig. 3 "Aa boil"). With papain pretreatment of 
antigen, all but two low molecular weight bands disappeared leaving only the 
smear in the upper portion of the lane (Fig. 3 lane "Aa pap"). The presence 
of the smear on western blots before or after boiling and papain digestion 
suggests that persistence of the antigen after treatment is occurring rather 
than aggregation or unveiling of antigen. 
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FIG. 2. Compilation of RIA data for all patients having a high antibody titer 
to Aa Y 4 showing the affect of boiling and papain digestion on antibody titers. 
Panel a is the tetanus toxoid positive control (4 subjects) and panel b is the data 
for AaY4 (32 subjects). The error bars indicate the standard error of the 
mean. 
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FIG. 3. A western blot using a low dilution (1/2) of patient serum showing 
the effect of boiling and papain digestion on AaY4. Bg is run as a control for 
papain digestion. 
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To determine which bands represent the immunodominant antigen for 
Aa Y 4, western blots were run and replicate lanes were stained with 
progressively less serum from 1/250 ml to 1/1024K ml (fig-4). With 
increasing dilution, all of the protein bands were eliminated leaving the 
smear in the upper portion of the lane when only 1/256K ml of serum was 
used. In the original western blot, a faint smear was visible even at 1/1024K. 
To determine the immunodominant antigens for the group of high responder 
patients, 1/I00K ml of serum from 31 subjects was incubated with a single 
lane. The results of this assay are summarized in Table 1. Note that sera 
from all 31 of these high responding patients react with the smear in the 
upper portion of the lane. Other bands are present for many of the patients at 
1/100K; however, the discrete bands with the highest prevalence ( l OOKd, 
98Kd, 85Kd) were found in only 34% of the subjects. In every patient (5 
subjects) where the serum was serially diluted beyond 1/I00K ml, only the 
smear was detected. 
The properties of the "smear" antigen are consistent with a carbohydrate 
(i.e. the antigen was heat and papain stable and did not focus into a discrete 
band on western blots). To test this more directly, AaY4 sonicate was 
subjected to a carbohydrate purification procedure involving extraction with 
phenoVwater followed by precipitation with cold ethanol. This preparation 
was run on a western blot and stained with 0.5 ml of patient serum. The 
appearance was much like that observed with papain digestion of Aa Y 4 (Fig. 
5). Interestingly, the two papain resistant low molecular weight bands 
copurified with the carbohydrate; however, these bands stained with 
Coomassie blue and appeared to be protein. 
22 
FIG. 4. A typical western blot of AaY4 illustrating the immunodominant 
antigens. Replicate lanes of AaY4 were run on polyacrylamide gel and 
transferred to nitrocellulose. Decreasing amounts of a patient's serum (1/250 
ml-1/1024K ml) were used in the incubation mixture for each lane to allow 
visualization of the immunodominant antigen with subsequent staining. Note 
that the discrete bands disappeared with decreasing amount of serum, but the 
"smear" was still visible in the upper portion of the western blot with a serum 
dilution utilizing 1/256K ml of serum. In the original western blot, the 
smear was also visible at 1/1024K. 
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FIG. 5 .  Comparison o f  papain digested AaY4 antigen with AaY4 
carbohydrate on a western blot. Patients' sera are used at a low dilution (1/2 
or O.5rnl) to reveal any antigens in the purified material. 
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TABLE 1 .  Prevalen ce of i n di vi du al bands on wes tern blot 
for Actinobacillus actinomycetemcomitans str ain Y4 in high 
responder patients 
Nu mber of i ndi vi du als res pondin g (%)b Ban da 
3 1  1 00% s me ar 
1 0  340/0 1 00Kd 
1 0  34% 98Kd 
1 0  34% 8 5Kd 
9 28% 9 9Kd 
9 28% 80Kd 
8 25% 6 8Kd 
7 21% 7 5Kd 
6 1 8% 87Kd 
5 1 5% 20 5Kd 
3 9% 1 80Kd 
3 9% 1 60Kd 
3 9% 60Kd 
2 6% 58Kd 
2 6% 1 8Kd 
1 3% 1 5Kd 
1 3% 2 5Kd 
1 3% 2 1 0Kd 
1 3% 90Kd 
a- Bands appearing on wes tern blot when s tained with 1/1  00,000 of 
a ml of serum in 4 ml of diluent 
b- 1 subject of the 32 was unavai lable for wes tern blot 
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The appearance of the Aa immunodominant antigen on western blots 
prompted us to determine if this antigen was the serotype b specific antigen 
which is thought to be a capsular polysaccharide (30). In double 
immunodiffusion analysis, the extracted carbohydrate preparation showed a 
line of identity with patient serum and rabbit serotype b specific antiserum 
(Fig. 6 panel A). No reaction was seen with serotype a or c specific antisera. 
In addition, western blots using the rabbit serotype b specific antiserum 
revealed a smear typical of that seen when using human serum (data not 
shown). 
Crossed immunoelectrophoresis was attempted to help establish whether 
the smear on western blot actually represented a single antigen. After several 
trials, it appeared the immunodominant antigen was not migrating at the 
required pH. The carbohydrate extract as well as whole Aa Y 4 sonicate was 
analyzed using immunoelectrophoresis. The antigen forming the precipitin 
bands did not migrate at pH 8.6 explaining why crossed 
immunoelectrophoresis was unsuccessful (Fig-6 panel B). 
It was considered likely that the carbohydrate extract contained 
lipopolysaccharide which might contribute to the smear observed on western 
blots. Actinobacillus actinomycetemcomitans lipopolysaccharide (AaLPS) 
was therefore analyzed on western blots and SDS-page gels (Coomassie and 
silver stained) (28). The AaLPS preparation contained a diffuse band in the 
upper portion of the lane which appeared very similar in silver stained gels 
or western blots to the carbohydrate preparation (data not shown). 
Coomassie staining revealed several protein bands in the AaLPS. 
To better assess the contribution of LPS to the diffuse band in western 
blots, the carbohydrate was further enriched. Two phenol/water extractions 
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FIG. 6. Double immunodiffusion and immunoelectrophoresis showing that 
serotype-b specific rabbit antiserum and high responder patients recognize 
the same irnmunodominant antigen. 
Panel A: A double immunodiffusion analysis (Ouchterlony technique) 
showing that rabbit serotype b specific antiserum and patient serum 
recognize the same antigen. Peripheral wells P, B, A, C contained: patient 
serum P, and Aa serotype B, A, C, serotype specific antisera respectively 
(SuI each of a 1:2 dilution). The center well (E) contained AaY4 
carbohydrate extract (40ul) 
Panel B: Immunoelectrophoresis of the immunodominant antigen at pH 
8.6. Well E contained l Oul of AaY4 carbohydrate extract and well S 
contained l Oul of Aa Y 4 sonicate. Two precipitin bands were noted when 
using the whole sonicate, and a single band with the carbohydrate extract. 
29 
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B 
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and cold ethanol precipitations were carried out on the Aa Y 4 sonicate. 
Further purification was accomplished using a concentrator with a 30kd 
molecular weight exclusion to remove low molecular weight material. 
Finally this preparation was passed over a lipid A binding column to remove 
LPS. Analysis of this preparation on SDS-page gels is presented in Fig. 7 
(Fig- 7 "Aacarb coomassie" "Aacarb silver"). This demonstrates the 
extracted antigen preparation before passage over the column. Note that the 
low molecular weight protein bands seen in Fig. 5 are not evident in the 
Coomassie stained gel. Discrete bands are also absent from the silver stained 
gel; however, the smear or diffuse band is present in the upper portion of the 
lane (Fig-7). The smear appears dark only at the top of the gel in this 
photograph; but the typical smear pattern was apparent up to the middle 
portion of the gel in the original. The carbohydrate extract was then passed 
over a lipid A binding affinity column to remove LPS and analyzed on SDS­
page gels. Actinobacillus actinomycetemcomitans lipopolysaccharide, 
which was papain treated, was used as a control. Silver staining of the AaLPS 
SDS-gels before and after passage over the column indicated that the column 
bound AaLPS effectively (Fig. 7 "AaLPSpap" "AaLPSpap column"). 
However, western blotting of the carbohydrate extract passed over the 
affinity column still revealed a smear in the upper portion of the lane 
suggesting that this antigen was not LPS (Fig. 7 "Aacarb column"). 
2. hnmunodominant Antigens of Actinobacillus actinomycetemcomitans 
Serotype b in Early Onset Periodontitis Patients 
In this set of experiments ,  the domi nant anti gens of early ons et 
peri odontitis patients with a range of antibody ti ters for Aa serotype 
b (including both black and white subjects )  were exami ned. The 
objecti ve of thes e  experi ments was to determine if the s erotype 
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FIG. 7. Persistence of the irnmunodominant antigen in the carbohydrate 
preparation after removing protein and LPS. The carbohydrate preparation 
was enriched by two cycles of phenol/water followed by cold ethanol 
precipitation. Low molecular weight materials were removed by using a 
concentrator with a 30Kd filter. LPS was used as a control to establish that 
the lipid A binding column would remove AaLPS. SDS-page gels were 
stained with Coomassie blue, silver or analyzed on western blot. Aacarb 
coomassie: SDS-page gel of AaY4 carbohydrate extract stained with 
coomassie blue, Aacarb silver: SDS-page gel of Aa Y 4 Carbohydrate extract 
stained with silver, AaLPSpap: SDS-page gel of AaY4 LPS that was digested 
with papain stained with silver, AaLPSpap column: SDS-page gel of AaY4 
LPS that has been digested with papain and passed over LPS binding affinity 
column stained with silver, Aacarb Column: western blot (using a 1/50 
dilution of patient serum) of Aa Y 4 carbohydrate extract that has been passed 
over an LPS binding affinity column. Although not apparent in the 
photograph, a single discrete band was detectable in the original western blot 
at 15kd. It appears that enough protein persisted, after all the purification 
steps, to be detected by the very sensitive western blot. 
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s peci fic  carbohydrate anti gen that was immunodominant i n  hi gh 
responding subjects (mos t  were black) was als o immunodominant in 
both b lack and w hi te  anti bo d y  p osi ti v e  su bj e c ts .  
Radioi mmunoass ays were completed on 99 early onset peri odonti tis 
pati ents (the early ons et periodonti tis subset of the 48 1 subject 
group) to find subjects with a range of antibody titers reacti ve with 
Aa Y 4. Eleven white patients wi th a positive antibody titer, including 
very low titers ,  were selected. Black s ubjects with similar anti body 
ti ters to Aa Y 4 were selected to compare with the white patients .  
The specifici ty o f  the antibody respons es o f  the 2 9  selected 
patients was then determi ned. Double immunodiffusion experiments 
were run to help assess the specificity of the antibody responses to 
AaY4. Serum from 1 8  of the 29 subjects produced a line of identity 
with an Aa Y 4 serotype specific  specific serum indicating that their  
responses were speci fic  (Fi g. 8) .  The specifici ty of the remaining 
subjects '  antibodi es was determined using the competi ti on ass ay. 
Examples of the ass ay i llus trating specific  and nonspecific  reactiviti es 
is s hown in Figure 9. Heavily loaded western blots of whole AaY4 
s oni cate were used to allow all anti gens to be represented in ample 
quantity. For each patient, four replicate lanes were stained us ing a 
pati ent's s erum that was ei ther untreated or preincubated wi th 
s erotype -a, -b(AaY4), or -c anti gen. In this example, only 
preabs orpti on of the specific  responder's s erum (subject A) with 
s erotype-b anti gen (lane bib) completely elimi nated the reacti vi ty 
pres ent i n  the control non-preabs orbed lane ( lane b/-).  
Pre abs orpti on with ei ther of the other two serotypes eliminated only 
cross reactive antigens wi th most of the reactivi ty remaining in the 
3 4  
FIG. 8. Identity of the immunodominant antigen with the serotype specific 
antigen. Double-immunodiffusion analysis (ouchterlony technique) showing 
that serum from a high reponding patient previously shown to recognize the 
same antigen as the rabbit serotype-b specific antiserum and patient serum 
(from responders with a range of antibody responses) recognize the same 
antigen in serotype-b sonicate that has been treated with protease K. 
Peripheral wells P and PHS contained patient serum (from the subjects with a 
range of antibody titers) and High responder serum(20ul of undiluted serum 
for each). The center well S contained SuI of serotype-b sonicate (originally 
having a protein concentration of 7ug/ml) that was treated with protease K. 
35 
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FIG. 9. Serological specificity of responses to Aa serotype b as detennined 
by the competition assay using the western blot technique. Patient A: a 
specific responder to serotype-b, Patient B: a patient that responded 
nonspecifically to serotype-b, b/a: blot of serotype-b stained with serum 
pre incubated with serotype-a antigen, bib: blot of serotype-b stained with 
serum preincubated with serotype-b antigen, b/c: blot of serotype-b stained 
with serum preincubated with serotype-c antigen, b/-: blot of serotype-b 
stained with untreated serum. 
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serum (lanes bla, b/c). This result indicated that this patient was 
responding specifically. In subject B, a non-specific responder , 
preabsorption of the serum with any of the three serotype antigens 
(lanes bla, bIb, b/c) eliminated all of the reactivity in the control 
lane (lane b/-). When this analysis was applied to the 1 1  subjects 
lacking precipitin lines in the double immunodiffusion experiment 
only 2 out of 1 1  were found to be responding specifically. Further 
examination of the data, showed that patients with an antibody titer 
of 43 ,000 units or greater demonstrated specific responses to 
serotype-b, while the lower responses tended to be against Aa 
common antigens This analysis allowed selection of 20 subjects from 
the original group having a specific response to AaY4. 
included 6 white and 14 black subjects. 
These 
To determine which antigen in the bacter ial sonicate was 
responsible for the antibody titer for each of the 20 patients , 
replicate western blot lanes were stained with increasing dilutions of 
patient serum in a limiting dilution analysis .  This allowed 
visualization of the immunodominant antigen at the end point. This 
assay was analogous to the radioimmunoassay (RIA) that was u sed to 
determine the antibody titer. Each western blot lane corresponds to 
a well of a microtiter plate used in the RIA. An example of this 
analysis is shown in Figure 1 0. As replicate lanes were stained with 
progressively less serum (from 10-4 to 1 0-6 ml) most of the antigen 
bands disappeared leaving only the immunodominant antigen 
apparent at the highest dilution of serum (i.e. endpoint). In this case 
the immunodominant antigen at the endpoint was a smeared antigen 
in the upper range of the lane. The results of this analysis for all 
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FIG. 10. The immunodominant antigen of Aa serotype b. A typical western 
blot of Aa serotype-b illustrating the immunodominant antigen for a 
particular patient. Replicate lanes of Aa serotype-b were run on 
polyacrylamide gel and transferred to nitrocellulose. Decreasing amounts of 
a patient's serum (1/250 ml-l/1024K ml) were used in the incubation mixture 
for each lane. Note that the descrete bands have disappeared with the 
decreasing amount of serum but the smear was still visible in the upper 
portion of the lane at 1/100K ml of serum. In the original blot it was also 
visible at l/lOOOK. 
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the subjects is summarized in Table 2. The data indicated that 95% 
( 1 9/20-total, 1 3/ 14 black, 6/6 white) of the specific seropositive 
subjects had a smeared antigen as the immunodominant antigen. 
One subject reacted with only a 72kd antigen and another reacted 
with both a 1 5kd and the smeared antigen as immunodominant 
antigens. All but these two patients gave a reaction of identity in 
double immunodiffusion experiments using serotype specific 
antiserum. The smear on western blot of the patient detecting the 
1 5Kd antigen had the same appearance as that observed for all the 
other patients. I believe this is also a response to the serotype 
specific antigen; the antibody titer was too low for a visible reaction 
in double immunodiffusion analysis. 
3. Irrununodominant Antigens of Actinobacillus actinomycetemcomitans 
Serotypes-a and-c in High Responder Patients 
Nineteen subjects with the highest anti-Aa serotype-a antibody titers and 
twenty one with the highest serotype-c antibody titers were selected from a 
group of 150 clinically characterized subjects. This was about 15% of the 
total group in each case. For serotype-a 11 were black and 8 white. For 
serotype-c 15 were black and 6 white. All but 4 of these subjects had early 
onset forms of periodontitis with 12JP, 6SP, and INP for serotype-a and 
11JP, 8SP, and 2NP for serotype-c. 
To determine which of these high responding patients were responding 
specifically to their respective Aa antigens, competition analysis was 
performed using all 3 Aa serotypes. The specificity of an individual patient's 
response is illustrated in Figure 11. Heavily loaded western blots of whole 
cell sonicate were used to allow all immunodominant antigens to be 
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TABLE 2. The immunodominant antigens of serologically specific 
early onset periodontitis patients for Actinobacillus 
a ctinomycetemcomitans serotype-b (AaY4) 
Subject Race Titer(RIAunits) Specific Dominant 
Response antigen(s)a 
1 W 940 n d  
2 W 9 5 5  n d  
3 W 1 ,400 n d  
4 B 1 ,400 n d  
5 B 1 ,800 n d  
6 B 3 ,5 0 0  n d  
7 B 6 ,000 + SMEAR, 1 5Kd 
8 W 1 0 , 5 00 n d  
9 B 1 3 ,500 n d  
1 0  B 18 ,700 + 72Kd 
1 1 W 3 2,000 n d  
1 2  B 42 ,600  + SMEAR 
1 3  W 64,000 + SMEAR 
1 4  B 64,000 + SMEAR 
1 5  B 1 22 , 3 00 + SMEAR 
1 6  B 1 28 , 000 + SMEAR 
1 7  B 149 ,500 + SMEAR 
1 8  W 1 9 2 ,000 + SMEAR 
1 9  W 1 96 , 3 00 + SMEAR 
2 0  B 1 98 ,400 + SMEAR 
2 1  B 230 ,400 + SMEAR 
2 2  B 230 ,400 + SMEAR 
2 3  B 243 , 200 + SMEAR 
2 4  B 254 ,7 00 + SMEAR 
2 5  B 254 ,7 00 + SMEAR 
2 6  W 402,900 + SMEAR 
2 7  W 5 0 6 ,800 + SMEAR 
2 8  B 7 3 2 , 200 + SMEAR 
2 9  W 7 9 3 , 600 + SMEAR 
a- Bands appearing on western blot when stained with 
decreasing amounts of serum ( 1 /250 ml- 1/ 1024,000ml) 
in4 ml of diluent 
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FIG. 1 1 .  Competition assay using the western blot technique to detennine the 
specificity of an individual patient's antibody response. Notice that 
preincubation of serum with antigen from any of the three serotypes 
removed antibody molecules reactive with that antigen on the blot (lanes a/a, 
bib, c/c). In contrast, in the control when there was no preabsorbtion of sera, 
there was reactivity in each lane (lanes a/-, b/-, c/-). When antigen 
preparations from the remaining two serotypes were used to preabsorb the 
sera, the results indicated a specific response for serotypes -b and -c but not 
for -a. For serotypes -b and -c preincubation with either of the remaining 
serotype antigens resulted in elimination of reactivity for Aa common 
antigens but allowed staining of serotype specific antigens (lanes b/a, b/c, c/a, 
clb). For serotype-a, preincubation of sera with antigen of any of the three 
serotypes completely eliminated reactivity with antigens present on the 
western blot (lanes a/a, alb, a/c). These results indicated that this patient 
responded specifically to serotypes -b and -c but not to serotype-a. a/a: blot 
of serotype-a stained with serum preincubated with serotype-a antigen, alb: 
blot of serotype-a stained with serum preincubated with serotype-b antigen, 
a/c: blot of serotype-a stained with serum pre incubated with serotype-c 
antigen, a/-: blot of serotype-a stained with untreated serum, b/a: blot of 
serotype-b stained with serum preincubated with serotype-a antigen, bib: 
blot of serotype-b stained with serum preincubated with serotype-b antigen, 
b/c: blot of serotype-b stained with serum preincubated with serotype-c 
antigen, b/-: blot of serotype-b stained with untreated serum, c/a: blot of 
serotype-c stained with serum preincubated with serotype-a antigen, clb: 
blot of serotype-c stained with serum pre incubated with serotype-b antigen, 
c/c: blot of serotype-c stained with serum pre incubated with serotype-c 
antigen, c/-: blot of serotype-c stained with untreated serum. 
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represented in ample quantity. Four replicate nitrocellulose lanes (a set of 
four for each serotype) were stained using patient serum that was either 
untreated or preincubated with serotype-a,-b, or-c antigen. For serotype-a, 
preincubation with antigen of any one of the three serotypes removed 
antibody molecules reactive with serotype-a antigen present on the blot (lanes 
a/a, alb, alc). Lane a/- was a control with no preabsorbtion of serum. The 
data indicated that this patient did not respond to serotype-a specifically 
because antigens from serotypes-b or-c could inhibit staining of a blot of 
serotype-a. Therefore, I concluded the response to serotype-a was only to 
cross-reactive antigens common between the three serotypes. For serotypes­
b and-c, preincubation with serotype-b or-c antigen respectively (lanes bib 
and c/c) removed all reactivity from the patient's serum. However, 
preabsorbtion with either of the other two remaining serotypes antigen (lanes 
bfa, b/c, cIa, c/b) eliminated only a small portion of the reactivity present in 
the patient's serum. Lanes b/- and c/- are controls with no preabsorbtion of 
serum. This indicated that the serum of this patient contained reactivity for 
serotype specific antigens of serotypes-b and-c. This patient therefore 
responded specifically to serotypes-b and-c but not specifically to serotype-a. 
This same analysis was used for all of the serotype-a and-c high responders to 
determine the specificity of each individual's response. Only about half of 
high responders were responding specifically to their respective antigen (9 of 
19 for a and 12 of 21 for c). It was common to find individuals that 
responded specifically to only one serotype. In some cases, however, 
individuals responded specifically to more than one serotype as was shown in 
Fig. 1 1 .  For serotype-a, 5 were black and 4 were white. For serotype-c 9 
were black and 3 were white. All but 2 of these subjects had early onset 
disease with 6JP, 3SP, ONP for serotype-a and 5JP, 5SP, 2NP for serotype-c. 
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Those individuals that did not respond specifically to the appropriate antigen 
(a or c) often specifically responded to serotype-b. Only the patients 
responding specifically to the appropriate Aa serotype were used in the 
studies to determine the dominant antigens. 
To establish the irnrnunodominant antigens for serotypes-a and-c, I 
used limiting dilution analysis on western blots. Replicate lanes were stained 
with progressively less serum (from 1/250 to 1/1024,000 of a rnI). With 
increasing dilution, most of the antigen bands disappeared leaving only the 
irnrnunodorninant antigen(s) apparent at the highest dilution of serum (i.e. 
endpoint). An example of this analysis is shown in Fig. 12. At a low serum 
dilution many discrete bands were present and a diffuse or smeared high 
molecular weight antigen was also present (lane 1/250). When the serum was 
further diluted to 1/1000 { 1/1000th ( 1 0-3) of a rnl of serum} ,  many of the 
discrete bands disappeared. Therefore, the antibody titer reactive with these 
antigens was low. In this case, the smeared diffuse antigen was not the 
immunodominant antigen as the titer for this antigen was low. It was also of 
interest to note that some of the antigens that displayed intense staining at the 
lowest dilution (ex. the band at approximately 50Kd) disappeared at a serum 
dilution of 1/1000. The intensity of staining of individual bands at a low 
dilution of serum did not always correlate with the observed antibody titer 
for a given antigen when the antibody was diluted out further. For this 
patient, a serum content of 1/64K (1/64,OOOth of a ml of serum) resulted in a 
dominant antigen that was a discrete band having a molecular weight of 90kd. 
Although not apparent in the photograph, the 90Kd antigen was visible at a 
serum dilution of 1/256K (1/256,000th of a ml of serum). Similar analysis 
was completed for all the high responder patients. For some patients a single 
antigen was stained at the endpoint. For most two or three antigens 
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FIG. 1 2. A typical western blot of Aa serotype-a illustrating the 
imrnunodominant antigen for a particular patient. Replicate lanes of Aa 
serotype-a were run on polyacrylamide gel and transferred to nitrocellulose. 
Decreasing amounts of a patient's serum (1/250 ml-1/1024K ml) were used 
in the incubation mixture for each lane. Note that antigens that have elicited 
low titer antibodies are apparent only at low dilutions of serum while the 
90Kd imrnunodominant antigen is still visible at a serum dilution of 1/64K 
(1/64,000 of a ml of serum). In the original western blot, the 
imrnunodominant antigen was also visible at 1/256K). 
mw 250 1 K 4K 1 6K 64K 256K 1 024K 
206K 
1 00K 
68K 
42K 
25K 
1 8K 
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remained at the endpoint with no individual having more than four. The data 
indicated that for serotype-a there were several different immunodominant 
antigens for different patients but none was present in more than 44.4% of 
the serotype-a high responders (table3) .  For serotype-c the 
immunodominant antigens included a number of discrete bands and a diffuse 
band typical of LPS or capsular polysaccharide (table4). Only two of these 
antigens were present in the majority of serotype-c high responders: 92% 
( 1 1/12) had the diffuse or smeared antigen and 67% (8/12) had an 
approximately l 5Kd antigen. 
To determine if the l 5Kd band was a protein antigen, two replicate lanes 
of a western blot of Aa serotype-c were stained using serum from a patient 
known to be responsive to this antigen. One of the lanes was left untreated 
while the other was exposed to protease K digestion. As shown in figure 1 3, 
protease K digestion eliminated the discrete low molecular weight bands in 
the 1 5Kd region of the blot. The enzyme did not appear to affect the smeared 
antigen. This result indicated that the 15Kd immunodominant band was a 
protein antigen. Competition assays revealed that the 15Kd antigen was a 
common antigen between the three serotypes while the smeared antigen was 
serotype specific. In Fig. 14, competition assays for serotype-c are shown 
for two patients: one that responded specifically to Aa serotype-c and one 
that did not. For the specific responder untreated serum stained both the 
smeared antigen as well as the 15Kd antigen (lane c/- patient A). The 1 5Kd 
antigen was eliminated from the blot by incubating the serum with antigen 
from any of the three serotypes (lanes cia, c/b, clc patient A). This indicated 
that this antigen was not serotype specific. In contrast, the smeared antigen 
was only eliminated when serum was incubated with serotype-c antigen (lane 
TABLE 3. Prevalence of individual bands on western blot 
4 
2 
2 
2 
1 
1 
1 
1 
for Actinobacillus actinomycetemcomitans serotype-a 
Number of individuals responding (%)b 
44.4% 
22.2% 
22.2% 
22.2% 
1 1 . 1 %  
1 1 . 1  % 
1 1 . 1  % 
1 1 . 1 %  
smear  
8 3 Kd 
1 5Kd 
14Kd 
1 03 Kd 
90Kd 
57Kd 
28Kd 
a- Bands appearing on western blot when stained with decreasing 
amounts of serum ( 1 /250 ml- 1/1D24,000ml)in 4 ml of diluent 
5 0  
b- 6 patients responded to a single antigen at endpoint, 3 responded 
to three antigens at endpoint 
1 1 
8 
4 
3 
2 
2 
2 
TABLE 4. Prevalence of individual bands on western blot 
for Actinobacillus actinomycetemcomitans serotype-c 
Number of individuals responding (%)b 
9 1 .6 %  
66.6% 
3 3 . 3 %  
25.0% 
1 6.6% 
1 6.6% 
1 6.6% 
Banda 
smear  
1 5Kd 
14Kd 
57Kd 
170Kd 
1 60Kd 
78Kd 
a- Bands appearing on western blot when stained with 
decreasing amounts of serum ( 1 /250 ml- 1/1 024,OOOml) 
in 4 ml of diluent 
5 1  
b- 5 patients responded to two antigens at endpoint,5 patients 
responded to three antigens at endpoint, 1  patient responded to four 
antigens at endpoint. 
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FIG. 1 3. A western blot using a low dilution (1/250 rnl) of patient serum 
showing the effect of protease K digestion on the antigens of Aa serotype-c. 
Note that the 15Kd band was eliminated from the western blot by the protease 
while this treatment had no affect on the smeared antigen. Aa-c: western 
blot of untreated antigen, Aa-c protease: western blot of Aa-c that was 
digested with protease K before staining. 
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FIG. 14. Competition assay using the western blot technique showing that the 
15Kd antigen is an Aa common antigen and the smeared antigen is a serotype 
specific antigen. Patient A: a specific responder to serotype-c, Patient B: a 
patient that responded nonspecifically to serotype-c, cia: blot of serotype-c 
stained with serum preincubated with serotype-a antigen, c/b: blot of 
serotype-c stained with serum preincubated with serotype-b antigen, c/c: 
blot of serotype-c stained with serum preincubated with serotype-c antigen, 
c/-: blot of serotype-c stained with untreated serum. 
subject 
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c/c patient A) and not with the other two antigens (lane cia, c,b patient A). 
Serum from the patient with the nonspecific response lacked reactivity with 
the smeared antigen but did recognize the 15Kd antigen (lane c/- patient B). 
The 15Kd antigen was again eliminated with antigen from any of the three 
serotypes (lanes cia, c/b, c/c patient B) confirming the lack of serotype 
specificity. 
The appearance of the smeared immunodominant antigen on western blot 
and its resistance to protease was consistent with either LPS or a 
carbohydrate antigen. To further characterize the antigen, double 
immunodiffusion analysis was performed. This analysis utilized serotype-c 
specific rabbit antisera which has been shown to have reactivity with mannan 
from serotype-c and no reactivity with LPS (3 1) .  Antigen from serotype-c 
was treated with protease K to remove protein antigens and then added to the 
center well. Serum from a patient known to be positive for the smeared 
antigen was placed in one peripheral well and the serotype specific rabbit 
antisera was placed in an adjacent peripheral well. This analysis resulted in a 
line of identity indicating that the non-protein antigen recognized by the 
rabbit antiserum was the same antigen as the immunodominant antigen 
recognized by the patient's serum (Fig. 15). This result was found for 9 of 1 1  
of the serotype-c specific high responders that had the smeared antigen as a 
dominant antigen. The remaining 2 subjects showed a reaction of non­
identity with the serotype specific antigen recognized by the rabbit 
antiserum. The immunodominant antigen in man is apparently the mannan 
described by Zambon (3 1). When antigen not subjected to proteolysis was 
used other precipitin lines were observed that were eliminated by the enzyme 
digestion indicating that the proteolytic digestion was effective. 
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FIG. 1 5 .  Double-immunodiffusion analysis (Ouchterlony technique) 
showing that rabbit serotype-c specific antiserum and patient serum 
recognize the same antigen in serotype-c sonicate that has been treated with 
protease K. Peripheral wells P and C contained patient serum and rabbit 
serotype-c specific antiserum respectively (20ul of undiluted serum for 
each). The center well S contained SuI of serotype-c sonicate (originally 
having a protein concentration of 7ug/ml) that was treated with protease K. 
Note precipitin lines between P and C. These are absorbtion lines which 
derive from the fact that the serotype specific rabbit antiserum was absorbed 
with antigen preparations from the other two serotypes. Therefore, the 
rabbit antiserum contains antigens form serotypes -a and -b. Several 
different concentrations of antigen and sera were used and only one 
precipitin line was found in any case. 
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DISCUSSION 
Analyses of the antibody reactive with AaY4 sonicate by RIA and 
western blot analysis strongly suggest that the immunodorninant antigen for 
Aa Y 4 is a carbohydrate. The immunodominant antigen is the antigen that is 
responsible for the observed antibody titer in the high responder subjects. 
When sera are used at high dilution, only high titer antibody measurable. 
The antigen detectable at the highest serum dilution on the western blot 
corresponds to the antigen responsible for the endpoint or antibody titer in 
the RIA. This antigen was heat stable, resistant to proteolytic digestion, 
purified with carbohydrate, and appeared like carbohydrate on western blot 
(i.e., carbohydrate does not focus into a discrete band on western blot). This 
antigen preparation contains the serotype-b specific antigen as demonstrated 
in double immunodiffusion analysis. It has been suggested that the type 
specific antigen of Aa Y 4 may represent capsular carbohydrate as it is a 
surface antigen readily detectable on whole cells using immunofluorescence 
(30). A lipid A binding affinity column which bound AaY4LPS failed to 
retain the "smear antigen" found on western blots of Aa Y 4 carbohydrate 
extract. This further supports the idea that the immunodorninant antigen may 
be a capsular polysaccharide. 
The next set of experiments examined the immunodominant antigen in 
AaY4 for antibody positive subjects that had a range of titers. This would 
determine if an immunodominant response to the serotype specific 
carbohydrate antigen was restricted to the high responding patients. To 
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determine if the immunodominant antigen for antibody positive 
subjects with a range of antibody titers would be the same 
immunodominant antigen found in the high responding subjects, 
patients were selected to include subjects of both races with a range of 
antibody titers to AaY4. The results showed that the 
immunodominant antigen of Aa Y 4 in antibody positive, serotype 
specific, early onset periodontitis patients was the serotype-b 
antigen as was previously found in earlier work limited to high 
responding patients. This was the case for the entire range of 
antibody specific responses although most of the very low titers 
were not Aa Y 4 specific. The competition (inhibition) assay showed 
that these low responding subjects generally had a specific response 
to serotype-a or-c. Thus, the assay probably measured low titer 
antibody directed towards cross reactive antigens when Aa Y 4 was 
used as the antigen for RIAs and western blots. 
The relationship between antibody response to the "smeared" 
antigen and race was also examined as initial work showed that most 
high responders to the smeared antigen were black. The second set 
of experiments indicate that both black and white subjects with 
specific antibody responses to Aa Y 4 were responding to the serotype 
specific antigen. While this seems to suggest the absence of a race 
affect on the antibody response, it should be understood that only 
those white subjects that had a specific response to Aa Y 4 were 
selected for the study. Gunsolley et al have shown that the majority 
of white subjects were not seropositive for AaY4, while the vast 
majority of black subjects were seropositive (in press Gunsolley et ai ,  
7).  It  was also noted that white subjects had lower antibody titers 
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than black subjects. Either white subjects do not respond to Aa Y 4 as 
frequently or with as high an antibody titer as black subjects, or they 
are not as frequently infected with Aa as blacks. 
A similar race effect has been shown for the antibody response to 
carbohydrate antigens of Haemophilus injluenzae, which has been 
attributed to an immune response gene associated with Km l 
immunoglobulin light chain allotype (5). It has also been suggested 
that major histocompatibility complex (specifically HLA-DQ 
molecules) may be responsible for the ability to respond to microbial 
mannans found in Aa (32). 
Examination of the data revealed that, with two exceptions, AaY4 
specific sera had an antibody titer of 43 ,000 units of antibody or 
greater. I examined the dominant antigens of the non-specific group 
and found that 4 out of 9 had a response to a smeared antigen. The 
response to the smeared antigen in these subjects was not serotype 
specific indicating that having antibody reactive with a smear is not 
sufficient to verify a response to the serotype specific antigen. 
Based on · these data, it is suggested that any study of antibody 
responses to antigens of Aa should include assays of specificity to try 
to assure that the patients have been exposed to the antigen of 
interest. Subjects with moderate to low antibody responses would 
include many individuals responding non-specifically to the serotype 
of interest. The result would be highly variable data with apparent 
immunodominant responses to different cross reactive antigens. 
Analysis of antibody reactive with A. actinomycetemcomitans serotype-a 
by limiting dilution analysis of western blots indicated that the 
immunodominant antigen for serotype-a was highly variable from patient to 
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patient. In contrast, most patients with high antibody titers to serotype-c had 
a 1 5Kd protein antigen and/or a diffuse band as their dominant antigens. 
Results of double immunodiffusion assays indicated that the smeared antigen 
is the serotype-c specific antigen. This antigen has been shown to be mannan 
and not LPS and appears to be part of the bacterial capsule (3 1) .  I 
particularly wanted to focus attention on dominant antigens that elicited a 
response in a majority of the high responder patients as it is the response to 
antigens that might provide information of prognostic value for the patient 
and clinician. These dominant antigens might also make good candidates for 
vaccines that could elicit protective antibody responses. For serotype-a, no 
particular dominant antigen was detectable in the majority of patients. 
Several dominant antigens were detected for serotype-c but only two were 
found in the majority of the serotype-c high responders. The 15Kd antigen 
was sensitive to protease K digestion and therefore appeared to be a protein. 
This antigen also appeared to be common to all three serotypes and was often 
present in western blots. This band could be eliminated in competition assays 
where serum was incubated with any of the three Aa serotype sonicates. This 
was not the case for the smeared serotype-c antigen. This antigen, which was 
recognized by the majority of serotype-c high responders, gave a reaction of 
identity with the serotype-c specific rabbit antisera in double 
immunodiffusion assays, indicating that this antigen was serotype-c specific. 
Furthermore, antigen could only be eliminated from western blots when 
serum was incubated with serotype-c sonicate but not-a or-b. 
When these results are compared with previous data from serotype-b it 
is apparent that the dominant antigen for serotype-b is similar to the 
serotype-c smeared antigen. Ouchterlony tests indicate that these antigens 
are the serotype specific carbohydrate and may represent capsular 
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polysaccharides. LPS has not been ruled out as the dominant antigen for 
serotype-b. However, analysis of sugar residues from the serotype specific 
carbohydrate by Zambon et al suggest that this antigen is not LPS (32). For 
the 2 subjects (2 of 12 serotype-c specific high responders) having a reaction 
of non-identity with the serotype-c specific rabbit antiserum, LPS remains a 
possibility. 
The serotype specific carbohydrate, which is known to be associated with 
the cell surface of Aa and may represent capsule, could be a virulence factor 
for Aa as it is for several other organisms. Purified serotype specific 
carbohydrate from Aa serotype-c is the serotype specific antigen and has 
been identified as mannan (30,3 1).  Capsular polysaccharide is known to 
inhibit phagocytosis of many bacteria (e.g., S. pneumoniae). In part, this 
appears to be the result of inhibition of the alternative complement pathway 
and decreased opsonization (10,12). Mannans isolated from S. cerevisiae 
have been shown to inhibit the respiratory burst and release of 
myeloperoxidase in phagocytes (29). Therefore, the serotype specific 
carbohydrate may be a virulence factor for Aa. 
Pneumococcal capsular polysaccharide has been shown to persist for long 
periods in mice; such polysaccharides have a half-life of up to 50 days (22). 
If the AaY4 carbohydrate is as resistant to degradation in vivo (by e.g., 
bacterial and PMN proteases) as it is in vitro, it could also persist for long 
periods of time within the periodontal tissues. Bacteria (14,21) and antigens 
of AaY4 (3,4) are observable within the periodontal tissues of juvenile 
periodontitis subjects. If the carbohydrate of AaY4 persists in the tissues, it 
might stimulate repeated cycles of antibody synthesis. Thus, long term 
persistence might explain the high titer of antibody reactive with this antigen 
in periodontitis patients. 
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If the immunodominant antigen is in fact a carbohydrate, the very issue of 
its potential immunogenicity is quite interesting. For example, a T dependant 
(IgG) response is not typically seen with a carbohydrate antigens. The T cell 
help could be obtained through presentation of the carbohydrate in the 
context of la. This has yet to be demonstrated for a carbohydrate antigen. 
Alternatively, either of the two proteins that copurify with the carbohydrate 
may be attached to the carbohydrate allowing Ia binding. Another possibility 
would be the availability of T cell help through poly clonal T cell activation in 
the periodontal tissues or lymph node. Future studies are planned to examine 
the behavior of the AaY4 carbohydrate antigen in different antigen 
presentation systems to determine the mechanism of production of the IgG 
response. 
High antibody titers to Aa Y 4 have been associated with localization 
and decreased severity of disease in juvenile periodontitis (6,20). Future 
studies will examine the relationship of antibody response to the 
immunodominant antigen as a function of disease severity and extent to see if 
antibody directed against this antigen is protective. Levels of antibody 
directed against the immunodominant antigen may also correlate with disease 
severity. If this is the case, measuring antibody to the immunodominant 
serotype specific carbohydrate antigen may decrease false positive results in 
antibody data due to cross-reactive antigens shared by the three serotypes. 
The immunodominant carbohydrate antigens for serotypes-b and-c appear 
to be potent antigens, at least for black subjects. The enormous antibody 
response (very high titer) observed for serotype-c and especially serotype-b 
may be due in part to the presence of highly immunogenic epitopes on these 
antigens or it may be due to long term persistence of these antigens in the 
periodontal tissues. Bacteria (14,21)  and antigens (3,4) of Aa are observable 
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in the periodontal tissues. The serotype-c and-b specific carbohydrate 
antigens have been shown to be stable to protease and the serotype-b specific 
antigen will withstand boiling for 45 minutes. Therefore, both potent 
immunogenicity as well as stability may explain the extremely high antibody 
titers that have been observed. 
I found that the immunodominant antigen was often not the most intensely 
staining antigen at low serum dilution. Some bands that stained quite 
intensely at low serum dilution did not titer out very far as blots were stained 
with increasing dilutions of serum. Therefore, I feel, it is important to dilute 
the serum with limiting dilution analysis as was done here. Staining intensity 
alone is not adequate to establish the immunodominance of particular 
antigens on western blots. 
I my conclusion, the immunodominant antigen for Aa serotype-a is 
highly variable from patient to patient. Most patients with high antibody 
titers to serotype-c responded to a 15Kd protein antigen and/or a smeared 
antigen. The immunodominant antigen for Aa Y 4 in both high responders 
and specific responders over a range of antibody titers was also a smeared 
antigen. This smeared antigen recognized by the patient's serum was also 
recognized by serotype specific rabbit antiserum. These data support the 
conclusion that the smeared immunodominant antigen was the serotype 
specific carbohydrate which appears to be part of the Aa capsule (30,3 1 ,32). 
The carbohydrate antigens therefore appear to be highly immunogenic and 
may be important antigens for Aa serotypes-b and-c. This potent 
immunogenicity may explain the enormous antibody titers that are found 
even when Aa Y 4 is found in low numbers. The immune response to these 
antigens may relate to the severity and extent of disease. Future work will 
examine the relationship of these responses to clinical status. 
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